請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/18911
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 張百恩 | |
dc.contributor.author | Yu-Chun Lin | en |
dc.contributor.author | 林瑜均 | zh_TW |
dc.date.accessioned | 2021-06-08T01:39:05Z | - |
dc.date.copyright | 2016-08-26 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-08-22 | |
dc.identifier.citation | Adams, L. M., M. J. Warburton and A. R. Hayman (2007). 'Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP).' Cell Biol Int 31(2): 191-195.
Angel, N. Z., N. Walsh, M. R. Forwood, M. C. Ostrowski, A. I. Cassady and D. A. Hume (2000). 'Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover.' J Bone Miner Res 15(1): 103-110. Arai, F., T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D. M. Anderson and T. Suda (1999). 'Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.' J Exp Med 190(12): 1741-1754. Battaglino, R., D. Kim, J. Fu, B. Vaage, X. Y. Fu and P. Stashenko (2002). 'c-myc is required for osteoclast differentiation.' J Bone Miner Res 17(5): 763-773. Baumbach, G. A., P. T. Saunders, C. M. Ketcham, F. W. Bazer and R. M. Roberts (1991). 'Uteroferrin contains complex and high mannose-type oligosaccharides when synthesized in vitro.' Mol Cell Biochem 105(2): 107-117. Blair, H. C., S. L. Teitelbaum, R. Ghiselli and S. Gluck (1989). 'Osteoclastic bone resorption by a polarized vacuolar proton pump.' Science 245(4920): 855-857. Boyce, B. F. (2013). 'Advances in the regulation of osteoclasts and osteoclast functions.' J Dent Res 92(10): 860-867. Boyce, B. F., E. Rosenberg, A. E. de Papp and L. T. Duong (2012). 'The osteoclast, bone remodelling and treatment of metabolic bone disease.' Eur J Clin Invest 42(12): 1332-1341. Boyle, W. J., W. S. Simonet and D. L. Lacey (2003). 'Osteoclast differentiation and activation.' Nature 423(6937): 337-342. Bucay, N., I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, W. J. Boyle and W. S. Simonet (1998). 'osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.' Genes Dev 12(9): 1260-1268. Burgess, T. L., Y. Qian, S. Kaufman, B. D. Ring, G. Van, C. Capparelli, M. Kelley, H. Hsu, W. J. Boyle, C. R. Dunstan, S. Hu and D. L. Lacey (1999). 'The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.' J Cell Biol 145(3): 527-538. Burstone, M. S. (1959). 'Histochemical demonstration of acid phosphatase activity in osteoclasts.' J Histochem Cytochem 7(1): 39-41. Cassady, A. I., A. Luchin, M. C. Ostrowski and D. A. Hume (2003). 'Regulation of the murine TRACP gene promoter.' J Bone Miner Res 18(10): 1901-1904. Chagraoui, H., M. Tulliez, T. Smayra, E. Komura, S. Giraudier, T. Yun, N. Lassau, W. Vainchenker and F. Wendling (2003). 'Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO.' Blood 101(8): 2983-2989. Chambers, T. J. (2000). 'Regulation of the differentiation and function of osteoclasts.' J Pathol 192(1): 4-13. Charles, J. F. and A. O. Aliprantis (2014). 'Osteoclasts: more than 'bone eaters'.' Trends Mol Med 20(8): 449-459. Chatani, M., Y. Takano and A. Kudo (2011). 'Osteoclasts in bone modeling, as revealed by in vivo imaging, are essential for organogenesis in fish.' Dev Biol 360(1): 96-109. Chen, A. T. and L. I. Zon (2009). 'Zebrafish blood stem cells.' J Cell Biochem 108(1): 35-42. Childs, L. M., E. P. Paschalis, L. Xing, W. C. Dougall, D. Anderson, A. L. Boskey, J. E. Puzas, R. N. Rosier, R. J. O'Keefe, B. F. Boyce and E. M. Schwarz (2002). 'In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.' J Bone Miner Res 17(2): 192-199. Darnay, B. G., V. Haridas, J. Ni, P. A. Moore and B. B. Aggarwal (1998). 'Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.' J Biol Chem 273(32): 20551-20555. David, J. P., K. Sabapathy, O. Hoffmann, M. H. Idarraga and E. F. Wagner (2002). 'JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms.' J Cell Sci 115(Pt 22): 4317-4325. de Vrieze, E., F. Sharif, J. R. Metz, G. Flik and M. K. Richardson (2011). 'Matrix metalloproteinases in osteoclasts of ontogenetic and regenerating zebrafish scales.' Bone 48(4): 704-712. Domon, T., M. Yasuda, M. Osanai, R. Suzuki, S. Takahashi, T. Yamamoto and M. Wakita (1998). 'Increase in odontoclast nuclei number by cell fusion: a three-dimensional reconstruction of cell fusion of human odontoclasts.' Anat Rec 252(3): 462-471. Dougall, W. C., M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De Smedt, E. Daro, J. Smith, M. E. Tometsko, C. R. Maliszewski, A. Armstrong, V. Shen, S. Bain, D. Cosman, D. Anderson, P. J. Morrissey, J. J. Peschon and J. Schuh (1999). 'RANK is essential for osteoclast and lymph node development.' Genes Dev 13(18): 2412-2424. Drake, F. H., R. A. Dodds, I. E. James, J. R. Connor, C. Debouck, S. Richardson, E. Lee-Rykaczewski, L. Coleman, D. Rieman, R. Barthlow, G. Hastings and M. Gowen (1996). 'Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts.' J Biol Chem 271(21): 12511-12516. Edsall, S. C. and T. A. Franz-Odendaal (2010). 'A quick whole-mount staining protocol for bone deposition and resorption.' Zebrafish 7(3): 275-280. Ek-Rylander, B., M. Flores, M. Wendel, D. Heinegard and G. Andersson (1994). 'Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro.' J Biol Chem 269(21): 14853-14856. Fleckenstein, E. and H. G. Drexler (1997). 'Tartrate-resistant acid phosphatase: gene structure and function.' Leukemia 11(1): 10-13. Franzoso, G., L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce and U. Siebenlist (1997). 'Requirement for NF-kappaB in osteoclast and B-cell development.' Genes Dev 11(24): 3482-3496. Galibert, L., M. E. Tometsko, D. M. Anderson, D. Cosman and W. C. Dougall (1998). 'The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.' J Biol Chem 273(51): 34120-34127. Gay, C. V. and W. J. Mueller (1974). 'Carbonic anhydrase and osteoclasts: localization by labeled inhibitor autoradiography.' Science 183(4123): 432-434. Grigoriadis, A. E., Z. Q. Wang, M. G. Cecchini, W. Hofstetter, R. Felix, H. A. Fleisch and E. F. Wagner (1994). 'c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.' Science 266(5184): 443-448. Halleen, J. M., S. L. Alatalo, H. Suominen, S. Cheng, A. J. Janckila and H. K. Vaananen (2000). 'Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.' J Bone Miner Res 15(7): 1337-1345. Halleen, J. M., M. Karp, S. Viloma, P. Laaksonen, J. Hellman, S. M. Kakonen, J. J. Stepan, S. Holmes, H. Vaananen and K. Pettersson (1999). 'Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.' J Bone Miner Res 14(3): 464-469. Halleen, J. M., S. L. Tiitinen, H. Ylipahkala, K. M. Fagerlund and H. K. Vaananen (2006). 'Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.' Clin Lab 52(9-10): 499-509. Hammond, C. L. and S. Schulte-Merker (2009). 'Two populations of endochondral osteoblasts with differential sensitivity to Hedgehog signalling.' Development 136(23): 3991-4000. Hayman, A. R., A. J. Bune and T. M. Cox (2000). 'Widespread expression of tartrate-resistant acid phosphatase (Acp 5) in the mouse embryo.' J Anat 196 ( Pt 3): 433-441. Hayman, A. R., A. J. Dryden, T. J. Chambers and M. J. Warburton (1991). 'Tartrate-resistant acid phosphatase from human osteoclastomas is translated as a single polypeptide.' Biochem J 277 ( Pt 3): 631-634. Hayman, A. R., S. J. Jones, A. Boyde, D. Foster, W. H. Colledge, M. B. Carlton, M. J. Evans and T. M. Cox (1996). 'Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis.' Development 122(10): 3151-3162. Hayman, A. R., P. Macary, P. J. Lehner and T. M. Cox (2001). 'Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells.' J Histochem Cytochem 49(6): 675-684. Helfrich, M. H., S. A. Nesbitt, P. T. Lakkakorpi, M. J. Barnes, S. C. Bodary, G. Shankar, W. T. Mason, D. L. Mendrick, H. K. Vaananen and M. A. Horton (1996). 'Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption.' Bone 19(4): 317-328. Hollberg, K., K. Hultenby, A. Hayman, T. Cox and G. Andersson (2002). 'Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport.' Exp Cell Res 279(2): 227-238. Honig, A., L. Rieger, M. Kapp, M. Krockenberger, M. Eck, J. Dietl and U. Kammerer (2006). 'Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study.' BMC Cancer 6: 199. Hotokezaka, H., E. Sakai, K. Kanaoka, K. Saito, K. Matsuo, H. Kitaura, N. Yoshida and K. Nakayama (2002). 'U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells.' J Biol Chem 277(49): 47366-47372. Hsu, H., D. L. Lacey, C. R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H. L. Tan, G. Elliott, M. J. Kelley, I. Sarosi, L. Wang, X. Z. Xia, R. Elliott, L. Chiu, T. Black, S. Scully, C. Capparelli, S. Morony, G. Shimamoto, M. B. Bass and W. J. Boyle (1999). 'Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.' Proc Natl Acad Sci U S A 96(7): 3540-3545. Hsu, K., J. P. Kanki and A. T. Look (2001). 'Zebrafish myelopoiesis and blood cell development.' Curr Opin Hematol 8(4): 245-251. Itzstein, C., F. P. Coxon and M. J. Rogers (2011). 'The regulation of osteoclast function and bone resorption by small GTPases.' Small GTPases 2(3): 117-130. Jimi, E., S. Akiyama, T. Tsurukai, N. Okahashi, K. Kobayashi, N. Udagawa, T. Nishihara, N. Takahashi and T. Suda (1999). 'Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.' J Immunol 163(1): 434-442. Jimi, E., I. Nakamura, L. T. Duong, T. Ikebe, N. Takahashi, G. A. Rodan and T. Suda (1999). 'Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.' Exp Cell Res 247(1): 84-93. Jung, K., M. Lein, C. Stephan, K. Von Hosslin, A. Semjonow, P. Sinha, S. A. Loening and D. Schnorr (2004). 'Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.' Int J Cancer 111(5): 783-791. Karin, M., Y. Cao, F. R. Greten and Z. W. Li (2002). 'NF-kappaB in cancer: from innocent bystander to major culprit.' Nat Rev Cancer 2(4): 301-310. Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, T. Wong, G. Campagnuolo, E. Moran, E. R. Bogoch, G. Van, L. T. Nguyen, P. S. Ohashi, D. L. Lacey, E. Fish, W. J. Boyle and J. M. Penninger (1999). 'Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.' Nature 402(6759): 304-309. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle and J. M. Penninger (1999). 'OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.' Nature 397(6717): 315-323. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y. X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney and W. J. Boyle (1998). 'Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.' Cell 93(2): 165-176. Lam, K. W., C. Y. Li, L. T. Yam and R. J. Desnick (1981). 'Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis.' Clin Biochem 14(4): 177-181. Lam, W. K., L. C. Lai and L. T. Yam (1978). 'Tartrate-resistant (band 5) acid phosphatase activity measured by electrophoresis on acrylamide gel.' Clin Chem 24(2): 309-312. Lang, P., M. Schultzberg and G. Andersson (2001). 'Expression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system.' J Histochem Cytochem 49(3): 379-396. Laperine, O., C. Blin-Wakkach, J. Guicheux, S. Beck-Cormier and P. Lesclous (2016). 'Dendritic-cell-derived osteoclasts: a new game changer in bone-resorption-associated diseases.' Drug Discov Today. Li, J., I. Sarosi, X. Q. Yan, S. Morony, C. Capparelli, H. L. Tan, S. McCabe, R. Elliott, S. Scully, G. Van, S. Kaufman, S. C. Juan, Y. Sun, J. Tarpley, L. Martin, K. Christensen, J. McCabe, P. Kostenuik, H. Hsu, F. Fletcher, C. R. Dunstan, D. L. Lacey and W. J. Boyle (2000). 'RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.' Proc Natl Acad Sci U S A 97(4): 1566-1571. Li, X., N. Udagawa, K. Itoh, K. Suda, Y. Murase, T. Nishihara, T. Suda and N. Takahashi (2002). 'p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function.' Endocrinology 143(8): 3105-3113. Lian, J. B., G. S. Stein, A. J. van Wijnen, J. L. Stein, M. Q. Hassan, T. Gaur and Y. Zhang (2012). 'MicroRNA control of bone formation and homeostasis.' Nat Rev Endocrinol 8(4): 212-227. Ljusberg, J., B. Ek-Rylander and G. Andersson (1999). 'Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases.' Biochem J 343 Pt 1: 63-69. Lomaga, M. A., W. C. Yeh, I. Sarosi, G. S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, A. van der Heiden, A. Itie, A. Wakeham, W. Khoo, T. Sasaki, Z. Cao, J. M. Penninger, C. J. Paige, D. L. Lacey, C. R. Dunstan, W. J. Boyle, D. V. Goeddel and T. W. Mak (1999). 'TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.' Genes Dev 13(8): 1015-1024. Ma, Y. L., R. L. Cain, D. L. Halladay, X. Yang, Q. Zeng, R. R. Miles, S. Chandrasekhar, T. J. Martin and J. E. Onyia (2001). 'Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.' Endocrinology 142(9): 4047-4054. Mak, T. W. and W. C. Yeh (2002). 'Immunology: a block at the toll gate.' Nature 418(6900): 835-836. Marks, S. C., Jr. (1989). 'Osteoclast biology: lessons from mammalian mutations.' Am J Med Genet 34(1): 43-54. Matsumoto, M., T. Sudo, T. Saito, H. Osada and M. Tsujimoto (2000). 'Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).' J Biol Chem 275(40): 31155-31161. Nakagawa, N., M. Kinosaki, K. Yamaguchi, N. Shima, H. Yasuda, K. Yano, T. Morinaga and K. Higashio (1998). 'RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.' Biochem Biophys Res Commun 253(2): 395-400. Nesbitt, S., A. Nesbit, M. Helfrich and M. Horton (1993). 'Biochemical characterization of human osteoclast integrins. Osteoclasts express alpha v beta 3, alpha 2 beta 1, and alpha v beta 1 integrins.' J Biol Chem 268(22): 16737-16745. Nesbitt, S. A. and M. A. Horton (1997). 'Trafficking of matrix collagens through bone-resorbing osteoclasts.' Science 276(5310): 266-269. Ota, K., P. Quint, M. Ruan, L. Pederson, J. J. Westendorf, S. Khosla and M. J. Oursler (2013). 'TGF-beta induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts.' Endocrinology 154(10): 3745-3752. Ota, K., P. Quint, M. M. Weivoda, M. Ruan, L. Pederson, J. J. Westendorf, S. Khosla and M. J. Oursler (2013). 'Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors.' Bone 57(1): 68-75. Pasqualetti, S., G. Banfi and M. Mariotti (2012). 'Osteoblast and osteoclast behavior in zebrafish cultured scales.' Cell Tissue Res 350(1): 69-75. Perez-Amodio, S., D. C. Jansen, T. Schoenmaker, I. M. Vogels, T. Reinheckel, A. R. Hayman, T. M. Cox, P. Saftig, W. Beertsen and V. Everts (2006). 'Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity.' Calcif Tissue Int 79(4): 245-254. Salo, J., P. Lehenkari, M. Mulari, K. Metsikko and H. K. Vaananen (1997). 'Removal of osteoclast bone resorption products by transcytosis.' Science 276(5310): 270-273. Schoppet, M., K. T. Preissner and L. C. Hofbauer (2002). 'RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.' Arterioscler Thromb Vasc Biol 22(4): 549-553. Sharif, F., M. A. de Bakker and M. K. Richardson (2014). 'Osteoclast-like Cells in Early Zebrafish Embryos.' Cell J 16(2): 211-224. Shui, C., B. L. Riggs and S. Khosla (2002). 'The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.' Calcif Tissue Int 71(5): 437-446. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H. L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T. M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee and W. J. Boyle (1997). 'Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.' Cell 89(2): 309-319. Suter, A., V. Everts, A. Boyde, S. J. Jones, R. Lullmann-Rauch, D. Hartmann, A. R. Hayman, T. M. Cox, M. J. Evans, T. Meister, K. von Figura and P. Saftig (2001). 'Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice.' Development 128(23): 4899-4910. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E. F. Wagner, T. W. Mak, T. Kodama and T. Taniguchi (2002). 'Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.' Dev Cell 3(6): 889-901. Takeshita, S., N. Namba, J. J. Zhao, Y. Jiang, H. K. Genant, M. J. Silva, M. D. Brodt, C. D. Helgason, J. Kalesnikoff, M. J. Rauh, R. K. Humphries, G. Krystal, S. L. Teitelbaum and F. P. Ross (2002). 'SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts.' Nat Med 8(9): 943-949. Tang, Y., X. Wu, W. Lei, L. Pang, C. Wan, Z. Shi, L. Zhao, T. R. Nagy, X. Peng, J. Hu, X. Feng, W. Van Hul, M. Wan and X. Cao (2009). 'TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation.' Nat Med 15(7): 757-765. Teti, A., H. C. Blair, S. L. Teitelbaum, J. A. Kahn, A. Carano, M. Grano, G. Santacroce, P. Schlesinger and A. Zambonin Zallone (1989). 'Cytoplasmic pH is regulated in isolated avian osteoclasts by a Cl-/HCO3- exchanger.' Boll Soc Ital Biol Sper 65(7): 589-595. Tezuka, K., K. Nemoto, Y. Tezuka, T. Sato, Y. Ikeda, M. Kobori, H. Kawashima, H. Eguchi, Y. Hakeda and M. Kumegawa (1994). 'Identification of matrix metalloproteinase 9 in rabbit osteoclasts.' J Biol Chem 269(21): 15006-15009. Udagawa, N., N. Takahashi, H. Yasuda, A. Mizuno, K. Itoh, Y. Ueno, T. Shinki, M. T. Gillespie, T. J. Martin, K. Higashio and T. Suda (2000). 'Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.' Endocrinology 141(9): 3478-3484. Vaananen, H. K. and P. L. Harkonen (1996). 'Estrogen and bone metabolism.' Maturitas 23 Suppl: S65-69. Vaananen, H. K. and M. Horton (1995). 'The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure.' J Cell Sci 108 ( Pt 8): 2729-2732. Vaananen, H. K., E. K. Karhukorpi, K. Sundquist, B. Wallmark, I. Roininen, T. Hentunen, J. Tuukkanen and P. Lakkakorpi (1990). 'Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts.' J Cell Biol 111(3): 1305-1311. Vaananen, H. K., H. Zhao, M. Mulari and J. M. Halleen (2000). 'The cell biology of osteoclast function.' J Cell Sci 113 ( Pt 3): 377-381. Wagner, E. F. and G. Karsenty (2001). 'Genetic control of skeletal development.' Curr Opin Genet Dev 11(5): 527-532. Walsh, N. C., M. Cahill, P. Carninci, J. Kawai, Y. Okazaki, Y. Hayashizaki, D. A. Hume and A. I. Cassady (2003). 'Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene.' Gene 307: 111-123. Wei, S., M. W. Wang, S. L. Teitelbaum and F. P. Ross (2002). 'Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling.' J Biol Chem 277(8): 6622-6630. Wong, B. R., D. Besser, N. Kim, J. R. Arron, M. Vologodskaia, H. Hanafusa and Y. Choi (1999). 'TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.' Mol Cell 4(6): 1041-1049. Xian, L., X. Wu, L. Pang, M. Lou, C. J. Rosen, T. Qiu, J. Crane, F. Frassica, L. Zhang, J. P. Rodriguez, J. Xiaofeng, Y. Shoshana, X. Shouhong, E. Argiris, W. Mei and C. Xu (2012). 'Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.' Nat Med 18(7): 1095-1101. Yan, T., B. L. Riggs, W. J. Boyle and S. Khosla (2001). 'Regulation of osteoclastogenesis and RANK expression by TGF-beta1.' J Cell Biochem 83(2): 320-325. Yasuda, H., N. Shima, N. Nakagawa, S. I. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. Goto, K. Yamaguchi, M. Kuriyama, T. Kanno, A. Murakami, E. Tsuda, T. Morinaga and K. Higashio (1998). 'Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.' Endocrinology 139(3): 1329-1337. Ylipahkala, H., K. M. Fagerlund, A. J. Janckila, B. Houston, D. Laurie and J. M. Halleen (2009). 'Specificity and clinical performance of two commercial TRACP 5b immunoassays.' Clin Lab 55(5-6): 223-228. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/18911 | - |
dc.description.abstract | 當骨頭受到周遭機械壓力或荷爾蒙影響,會進行骨頭的重建修復作用,骨頭進行重建時會包含骨質的破壞吸收和骨頭的再生。當骨頭要進行重建時,骨表面的造骨細胞釋放出一些化學訊號因子促使蝕骨細胞遷移到需要重建骨質的地方,形成多核的成熟蝕骨細胞。接著成熟的蝕骨細胞進行骨質溶蝕作用,此時蝕骨細胞釋放溶小體內的酵素,這些酵素於酸性環境才有活性,氫離子幫浦會釋出氫離子,使外在環境處於酸性狀態,釋出鈣離子與磷酸根離子。分解之後,造骨細胞再過來進行骨頭重建再生。所以蝕骨細胞與造骨細胞在骨吸收和骨形成之間的耦合過程中扮演十分重要的角色。蝕骨細胞進行溶蝕時所釋放出的酵素包含tartrate resistant acid phosphatase (TRAP)、cysteine proteases (例如 cathepsin K)等。其中抗酒石酸磷酸酶 (Tartrate- resistant acid phosphatase, TRAP) 普遍存在於蝕骨細胞,可以作為蝕骨細胞的標記物。
所以我的目標是進行蝕骨細胞特異性基因Acp5b (=TRAP)啟動子(promoter)的轉殖實驗,並用紅色及綠色螢光標記,遠程目標可以進一步利用細胞毒殺的方式毒殺這些蝕骨細胞並觀察骨頭再生的情形。實驗以斑馬魚為模式生物,將斑馬魚Acp5b基因的啟動子1.2kb片段與綠色及紅色兩種螢光蛋白報導基因結合形成結構體,在斑馬魚受精卵約十幾分鐘一個細胞期時(15-30 min),以顯微注射的方式注入斑馬魚受精卵中,期望能夠在斑馬魚轉殖實驗中,藉由觀察紅色綠色螢光的表現及分佈位置,而得知蝕骨細胞在斑馬魚發育過程中的表現情形以及分布。 實驗結果顯示,在斑馬魚眼睛及骨頭分佈看得到螢光的訊號,成功進行acp5b的cloning,並得到多組F2的stable line。蝕骨細胞大致上分布在頭骨、鰓蓋、尾鰭、背鰭、臀鰭以及脊椎骨上下緣。大約在三天可以看到魚眼睛的螢光訊號,約五天會發現小魚的腎臟也開始出現蝕骨細胞轉殖螢光訊號,一週可發現頭部開始產生蝕骨細胞螢光訊號,10天尾柄處也開始看得到螢光訊號。到了兩週開始,及椎骨上下緣出現螢光表現, 3週可發現胸鰭、背鰭、臀鰭長出後也產生螢光訊號。接著等斑馬魚性成熟(約兩個月大)進行截尾觀察尾鰭再生的蝕骨細胞分佈,但我們在截尾這部份未發現蝕骨細胞acp5b的螢光訊號,推測控制大魚尾鰭再生的增強子可能位於另一個控制斑馬魚TRAP的基因acp5a上面。這個實驗記錄斑馬魚生長階段蝕骨細胞的分佈,並得知尾鰭骨頭再生過程acp5b不會表現。 在後續遠程實驗的部分我們可用細胞毒殺的方式觀察蝕骨細胞毒殺後骨頭的生長分布,毒殺細胞所需的reductase還原酶的cDNA已經跟Dr.Peter F.Searle實驗室取得,之後可以進一步作出這些還原酶的construct,再利用我們的acp5b啟動子啟動這些帶有還原酶的construct,以細胞毒殺的方式毒殺這些蝕骨細胞並觀察骨頭再生的情形。 | zh_TW |
dc.description.abstract | Bone remodeling will occur to rebuild and repair bone when it encounter mechanical stress or hormonal influence. The procedures of bone remodeling involve bone destruction, absorption, and bone regeneration. During bone remodeling, osteoblasts on the bone surface will release some signal factors for promoting osteoclasts to migrate to the site where needed to be re-built, and forming mature multinucleated osteoclasts. Matured osteoclasts dissolve bone by secreting acid and enzymes that degrade the organic bone matrix in this acidic environment. Before osteoclasts break down, osteoblasts replace them when receiving signals and produce new bon matrix. So the coupling between osteoclasts and osteoblasts play a cruial role in the process of bone resorption and formation. For the purpose of degrading bone matrix, absorbing osteoclasts release some enzymes like tartrate resistant acid phosphatase (TRAP), cysteine proteases (for example, cathepsin K) and so on. Among them, TRAP, abundant in osteoclasts, can be used as an osteoclast marker.
My research goal is to do transgenic assay of osteoclast-specific Acp5b (= TRAP) gene promoter, using red and green fluorescent proteins as reporter genes to label osteoclasts and to track their development. To this aim, I use zebrafish as a model animal and make a construct harboring 1.3kb zebrafish Acp5b promoter and red- and green-fluorescent protein reporter genes to label osteoclasts. Then, these constructs were microinjected into one-cell stage of zebrafish embryos. The expressions of EGFP and DsRed were observed. My results reveal that the fluorescence signals are visible in zebrafish eye and around the bones in transient assays (F0). Then I screened F0 and obtained F1 stable lines. I got 17 stable lines in which DsRed can be observed in the eyes. However, only two lines also express DsRed reporter gene in osteoclasts. I found that DsRed-labelled osteoclasts were broadly distributed in the skull, gill cover, pectoral fin, tail fin, dorsal fin, anal fin and upper and lower edges of dorsal and ventral spines. In addition, to monitor the expression of Acp5b gene in osteoclasts during fin regeneration, I employed fin amputation-regeneration measures in the stable zebrafish line F1 (No. 7 and 16, about 2 month dpf). However, fluorescent signals were not detected in osteoclasts after amputation. Presumably, the enhancers to control TRAP expression in zebrafish osteoclasts during tail fin regeneration may be located in another TRAP gene, Acp5a. My experiments record the distribution of zebrafish osteoclasts in early developmental stages. In the future, we can apply cytotoxicity using a bacterial nitroreductase to convert a prodrug, Metronidazole, into a cytotoxic metabolite to ablate osteoclasts and observe the bone morphology in the absence of osteoclasts during zebrafish bone growth. By this way, we can evaluate the cell function of osteoclast during bone growth and regeneration | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T01:39:05Z (GMT). No. of bitstreams: 1 ntu-105-R03450012-1.pdf: 4428369 bytes, checksum: d45e45e2bda78f5e549e5f950b89f0fd (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 目錄
口試委員會審定書 ……………………………………………………………… 1 誌謝………………………………………………………………………………. 2 中文摘要…………………………………………………………………………. 3 英文摘要…………………………………………………………………………. 5 壹、 前言……………………………………………………………………. 8 一. 骨質重塑作用與蝕骨細胞……………………………………………. 8 二. 蝕骨細胞與骨細胞和造骨細胞間的交互作用………………………. 9 三. 蝕骨細胞(osteoclast)的特性 …………………………………………. 11 四. 蝕骨細胞的分化及活化………………………………………………. 14 五. 蝕骨細胞的骨吸收作用機制…………………………………………. 20 六. 斑馬魚早期造血組織…………………………………………………. 24 七. 抗酒石酸磷酸酶與蝕骨細胞的關係…………………………………. 26 八. 抗酒石酸磷酸酶TRAP………………………………………………. 27 九. 目前已知人類及魚類TRAP(ACP5)分佈資訊………………………. 29 十. 研究動機………………………………………………………………. 33 貳、實驗材料……………………………………………………………………. 35 參、實驗方法……………………………………………………………………. 39 肆、結果…………………………………………………………………………. 47 伍、討論…………………………………………………………………………. 50 陸、未來展望與研究方向………………………………………………………… 53 柒、圖表…………………………………………………………………………. 54 捌、參考文獻……………………………………………………………………. 72 | |
dc.language.iso | zh-TW | |
dc.title | 蝕骨細胞特異性基因啟動子Acp5b 轉殖實驗及觀察在發育過程蝕骨細胞的分佈 | zh_TW |
dc.title | Transgenic Assay of Osteoclast-Specific Acp5b Gene Promoter and Observing the Distribution of Osteoclasts | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 姚宗珍,張玉芳 | |
dc.subject.keyword | 蝕骨細胞,TRAP(ACP5),骨再生作用,斑馬魚,發育, | zh_TW |
dc.subject.keyword | osteoclast,acp5b,zebrafish,bone regeneration,development, | en |
dc.relation.page | 81 | |
dc.identifier.doi | 10.6342/NTU201603338 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2016-08-22 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-1.pdf 目前未授權公開取用 | 4.32 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。